Invention Grant
- Patent Title: Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections
-
Application No.: US16624140Application Date: 2018-06-26
-
Publication No.: US11639350B2Publication Date: 2023-05-02
- Inventor: Zhao-Kui Wan , Yimin Jiang , Xuedong Dai , Qian Liu , Wing Shun Cheung , Gang Deng , Liqiang Fu
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: Ice Miller LLP
- Priority: WOPCT/CN2017/090266 20180627
- International Application: PCT/CN2018/092849 WO 20180626
- International Announcement: WO2019/001420 WO 20190103
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D417/04 ; C07D417/14 ; A61P31/20
Abstract:
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject, and the compound has the structure of Formula I including any possible deuterated isomers, stereoisomers or tautomeric forms thereof.
Public/Granted literature
- US20200172532A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Public/Granted day:2020-06-04
Information query
